NCT00324766
- Conditions
- Cardiogenic Shock, Cardiovascular Diseases, Heart Diseases, +11 more
- Locations
-
- Department of Cardiology, Ulleval University Hospital Oslo, Norway
Clinical trial condition
Cardiogenic Shock
Explore clinical trials studying Cardiogenic Shock. Study availability and eligibility vary by location and protocol.
158 public trials
67 recruiting studies
Cardiogenic Shock trial results
NCT00469248
- Conditions
- Cardiogenic Shock, Cardiovascular Diseases, Heart Diseases, +12 more
- Locations
-
- Department of Medicine III, Klinikum Krollwitz, Martin Luther University Halle, Saxony-Anhalt, Germany
Active, Not Recruiting
Augmented Pacing for Shock in the Cardiac Intensive Care Unit
NCT06713668
- Conditions
- Arrhythmias, Cardiac, Bradycardia, Cardiogenic Shock, +12 more
- Locations
-
- Vanderbilt University Medical Center Nashville, Tennessee, United States
Active, Not Recruiting
Can Escalation Reduce Acute Myocardial Infarction Mortality in Cardiogenic Shock
NCT05800951
- Conditions
- Acute Myocardial Infarction, Acute Myocardial Infarction With ST Elevation, Acute Myocardial Infarction of Left Ventricle, +20 more
- Locations
-
- Loma Linda University Medical Center Loma Linda, California, United States
- Ronald Reagan UCLA Medical Center Los Angeles, California, United States
- Providence St. Joseph Hospital Orange Orange, California, United States
- St. Anthony Hospital Lakewood, Colorado, United States
Active, Not Recruiting
Effect of Early Empagliflozin Initiation in Cardiogenic Shock.
NCT07450417
- Conditions
- Cardiogenic Shock, Cardiovascular Diseases, Heart Diseases, +11 more
- Locations
-
- Chru Nancy Vandœuvre-lès-Nancy, France
Active, Not Recruiting
Empagliflozin's Microcirculatory Effects in Cardiogenic Shock: an Ancillary Pilot Study of the EMPASHOCK Trial
NCT07141355
- Conditions
- Cardiogenic Shock, Cardiovascular Diseases, Heart Diseases, +11 more
- Locations
-
- Hôpitaux Universitaires de Strasbourg Strasbourg, France
Active, Not Recruiting
A Safety and Efficacy Trial of Istaroxime for Cardiogenic Shock Stage C
NCT05975021
- Conditions
- Cardiogenic Shock, Cardiovascular Diseases, Heart Diseases, +10 more
- Locations
-
- Tufts Medical Center Boston, Massachusetts, United States
- Oregon Health and Sciences University Portland, Oregon, United States
- Sanatorio Güemes Capital Federal, Buenos Aires, Argentina
- Sanatorio De la Trinidad Palermo Capital Federal, Buenos Aires, Argentina
Active, Not Recruiting
Low-Dose Dobutamine and Single-Dose Tocilizumab in Acute Myocardial Infarction With High Risk of Cardiogenic Shock
NCT05350592
- Conditions
- Acute Myocardial Infarction, Cardiogenic Shock, Cardiovascular Diseases, +13 more
- Locations
-
- Rigshospitalet, Copenhagen University Hospital Copenhagen, Denmark